Corrigendum to "Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease

The Hisayama Study" [Atherosclerosis 231 (2) (2013) 261-267]

Toshiharu Ninomiya, Masaharu Nagata, Jun Hata, Yoichiro Hirakawa, Mio Ozawa, Daigo Yoshida, Tomoyuki Ohara, Hiro Kishimoto, Naoko Mukai, Masayo Fukuhara, Takanari Kitazono, Yutaka Kiyohara

研究成果: ジャーナルへの寄稿コメント/討論

元の言語英語
ページ(範囲)344-345
ページ数2
ジャーナルAtherosclerosis
234
発行部数2
DOI
出版物ステータス出版済み - 1 1 2014

Fingerprint

Eicosapentaenoic Acid
Arachidonic Acid
Atherosclerosis
Cardiovascular Diseases
Serum
corrigendum

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用

@article{4bfbab85bb2e4be699347ff5018674cc,
title = "Corrigendum to {"}Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: The Hisayama Study{"} [Atherosclerosis 231 (2) (2013) 261-267]",
author = "Toshiharu Ninomiya and Masaharu Nagata and Jun Hata and Yoichiro Hirakawa and Mio Ozawa and Daigo Yoshida and Tomoyuki Ohara and Hiro Kishimoto and Naoko Mukai and Masayo Fukuhara and Takanari Kitazono and Yutaka Kiyohara",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.atherosclerosis.2014.03.033",
language = "English",
volume = "234",
pages = "344--345",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Corrigendum to "Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease

T2 - The Hisayama Study" [Atherosclerosis 231 (2) (2013) 261-267]

AU - Ninomiya, Toshiharu

AU - Nagata, Masaharu

AU - Hata, Jun

AU - Hirakawa, Yoichiro

AU - Ozawa, Mio

AU - Yoshida, Daigo

AU - Ohara, Tomoyuki

AU - Kishimoto, Hiro

AU - Mukai, Naoko

AU - Fukuhara, Masayo

AU - Kitazono, Takanari

AU - Kiyohara, Yutaka

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84900871840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900871840&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2014.03.033

DO - 10.1016/j.atherosclerosis.2014.03.033

M3 - Comment/debate

VL - 234

SP - 344

EP - 345

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -